Jan 9, 2026 07:00AM
Jan 9, 2026 07:00AM
Dec 18, 2025 07:03AM
Dec 18, 2025 07:02AM
Nov 6, 2025 04:05PM
Aug 14, 2025 07:00AM
Aug 14, 2025 07:00AM Athira Pharma Presents ATH-1105 Phase 1 Trial Results at ALS Nexus 2025
Aug 7, 2025 04:05PM
May 13, 2025 11:00AM
May 9, 2025 04:05PM
Jul 9, 2024 07:00AM
May 15, 2024 04:05PM
Nov 9, 2023 04:05PM
Aug 10, 2023 04:05PM Athira Pharma Reports Second Quarter 2023 Financial Results and Pipeline and Business Updates
May 11, 2023 04:05PM
Jan 5, 2023 07:00AM
Jan 5, 2023 07:00AM
May 12, 2022 08:00AM
May 5, 2022 08:04AM
May 5, 2022 08:00AM
May 5, 2022 08:00AM Athira Mails Letter to Shareholders Emphasizing the Company’s Strong Position and Qualified Board as it Enters Pivotal Chapter
May 5, 2022 07:30AM
May 4, 2022 07:00AM
Apr 27, 2022 08:30AM
Apr 11, 2022 08:00AM
Mar 24, 2022 04:05PM
Mar 24, 2022 04:05PM
Nov 10, 2021 04:05PM Athira Pharma Reports Third Quarter 2021 Financial Results and Business Update
Nov 10, 2021 04:05PM
Aug 16, 2021 04:01PM
Aug 16, 2021 04:01PM
Aug 10, 2021 11:00AM
Jun 18, 2021 09:21AM
Jun 8, 2021 09:54AM
Jun 8, 2021 04:38AM Athira Pharma Inc. (ATHA) call put ratio 4 calls to 1 put
Jun 7, 2021 01:29PM
May 13, 2021 04:02PM
May 13, 2021 04:02PM
Apr 16, 2021 09:20AM
Mar 25, 2021 04:02PM
Mar 25, 2021 04:02PM
Mar 10, 2021 07:07AM Athira Pharma (ATHA) Management Meeting Takeaways - Goldman Sachs
Oct 13, 2020 09:27AM
Oct 13, 2020 08:24AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All